Real-time enrollment status for this rhabdomyosarcoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:49 PM UTC
| NCT Number | NCT05304585 |
| Recruiting Status | Recruiting |
| Condition | Rhabdomyosarcoma |
| Phase | PHASE3 |
| Target Enrollment | 205 participants |
| Active Locations | 166 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 16, 2026: Clinical trial NCT05304585 is currently recruiting participants. This phase3 study for rhabdomyosarcoma is actively seeking new participants at 166 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05304585 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 166 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05304585 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.